ClinicalTrials.govpublic full text
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI
diabetes mellitus, type 2, exocrine pancreatic insufficiency
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 332703
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.